statistiche ricercatore

Nome	#
miR-340 predicts glioblastoma survival and modulates key cancer hallmarks through down-regulation of NRAS	70
Aptamer-miRNA-212 Conjugate Sensitizes NSCLC Cells to TRAIL	49
Inhibition of Receptor Signaling and of Glioblastoma-derived Tumor Growth by a Novel PDGFRbeta Aptamer.	43
Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer	42
Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.	41
MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b	40
miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells	38
An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells.	37
Targeting Insulin Receptor with a Novel Internalizing Aptamer	36
miR-221/222 overexpression in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ.	27
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED.	26
c-FLIPL enhances anti-apoptotic Akt functions by modulation of Gsk3β activity.	26
Electrochemical detection of miRNA-222 by use of a magnetic bead-based bioassay.	26
Selection of RNA aptamers targeting hypoxia in cancer	18
Totale	519

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2018/2019	9	0	0	0	0	0	0	0	0	0	0	0	9
2019/2020	73	27	2	0	2	0	6	0	5	0	9	12	10
2020/2021	35	5	3	6	0	5	3	0	1	0	0	0	12
2021/2022	78	0	0	0	0	0	3	3	4	16	8	15	29
2022/2023	152	13	5	11	5	23	15	0	21	30	22	5	2
2023/2024	86	2	13	3	8	4	25	6	20	1	4	0	0
Totale													519